Related Experiment Video
Updated: Jul 16, 2026

Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination
Published on: August 24, 2015
Persistent B19 infection in immunocompetent individuals: implications for transfusion safety
Jean-Jacques Lefrère1, Annabelle Servant-Delmas, Daniel Candotti
1Institut National de la Transfusion Sanguine, 6 Rue Alexandre Cabanel, 75015 Paris, France.
Parvovirus B19 (B19) DNA can persist for years in immunocompetent individuals, particularly multitransfused patients. This study confirms long-term B19 persistence, challenging previous assumptions about viral clearance in non-immunodeficient hosts.
Area of Science:
- Virology
- Immunology
- Hematology
Background:
- Previous studies suggested parvovirus B19 (B19) persistence in immunocompetent individuals, but relied on limited cross-sectional data.
- Understanding the long-term presence of B19 in non-immunodeficient populations is crucial for transfusion safety and disease management.
Observation:
- Serial samples from multitransfused patients with hemoglobinopathies and pregnant women were analyzed for B19 markers.
- Persistent B19 viral DNA was detected in 8% of red cell recipients over 1-3 years.
- A significantly lower prevalence (0.8%) of detectable B19 DNA and IgG was found in pregnant women.
Findings:
- Long-term persistence of parvovirus B19 DNA is frequent in multitransfused patients.
- The virus can remain detectable for several years post-infection in non-immunodeficient individuals.
- B19-specific IgG was consistently found in patients with persistent viral DNA.
Implications:
- These findings highlight the potential for chronic B19 infections in specific immunocompetent groups.
- The results have implications for blood transfusion screening and management of B19 in vulnerable patient populations.
- Further research is warranted to elucidate the mechanisms of B19 persistence and its clinical significance.
Related Concept Videos
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Rh Blood Group
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

